These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20513406)

  • 21. Multiple conformations of the nucleotide site of Kinesin family motors in the triphosphate state.
    Naber N; Larson A; Rice S; Cooke R; Pate E
    J Mol Biol; 2011 May; 408(4):628-42. PubMed ID: 21277856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EPR spectroscopy shows a microtubule-dependent conformational change in the kinesin switch 1 domain.
    Naber N; Rice S; Matuska M; Vale RD; Cooke R; Pate E
    Biophys J; 2003 May; 84(5):3190-6. PubMed ID: 12719248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structural basis of force generation by the mitotic motor kinesin-5.
    Goulet A; Behnke-Parks WM; Sindelar CV; Major J; Rosenfeld SS; Moores CA
    J Biol Chem; 2012 Dec; 287(53):44654-66. PubMed ID: 23135273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression.
    Skoufias DA; DeBonis S; Saoudi Y; Lebeau L; Crevel I; Cross R; Wade RH; Hackney D; Kozielski F
    J Biol Chem; 2006 Jun; 281(26):17559-69. PubMed ID: 16507573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monastrol inhibition of the mitotic kinesin Eg5.
    Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
    J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loop L5 acts as a conformational latch in the mitotic kinesin Eg5.
    Behnke-Parks WM; Vendome J; Honig B; Maliga Z; Moores C; Rosenfeld SS
    J Biol Chem; 2011 Feb; 286(7):5242-53. PubMed ID: 21148480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinesin-5: cross-bridging mechanism to targeted clinical therapy.
    Wojcik EJ; Buckley RS; Richard J; Liu L; Huckaba TM; Kim S
    Gene; 2013 Dec; 531(2):133-49. PubMed ID: 23954229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparity in allosteric interactions of monastrol with Eg5 in the presence of ADP and ATP: a difference FT-IR investigation.
    Wojcik EJ; Dalrymple NA; Alford SR; Walker RA; Kim S
    Biochemistry; 2004 Aug; 43(31):9939-49. PubMed ID: 15287721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics and motility of the Eg5 microtubule motor.
    Lockhart A; Cross RA
    Biochemistry; 1996 Feb; 35(7):2365-73. PubMed ID: 8652578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleotide-dependent displacement and dynamics of the α-1 helix in kinesin revealed by site-directed spin labeling EPR.
    Yasuda S; Yanagi T; Yamada MD; Ueki S; Maruta S; Inoue A; Arata T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):911-6. PubMed ID: 24361895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doing the methylene shuffle--further insights into the inhibition of mitotic kinesin Eg5 with S-trityl L-cysteine.
    Abualhasan MN; Good JA; Wittayanarakul K; Anthony NG; Berretta G; Rath O; Kozielski F; Sutcliffe OB; Mackay SP
    Eur J Med Chem; 2012 Aug; 54():483-98. PubMed ID: 22749640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5.
    Debonis S; Skoufias DA; Indorato RL; Liger F; Marquet B; Laggner C; Joseph B; Kozielski F
    J Med Chem; 2008 Mar; 51(5):1115-25. PubMed ID: 18266314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of novel scaffolds to inhibit human mitotic kinesin Eg5 targeting the second allosteric binding site using in silico methods.
    Makala H; Ulaganathan V
    J Recept Signal Transduct Res; 2018 Feb; 38(1):12-19. PubMed ID: 29041840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
    Wiltshire C; Singh BL; Stockley J; Fleming J; Doyle B; Barnetson R; Robson CN; Kozielski F; Leung HY
    Mol Cancer Ther; 2010 Jun; 9(6):1730-9. PubMed ID: 20515952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photocontrol of the mitotic kinesin Eg5 using a novel S-trityl-L-cysteine analogue as a photochromic inhibitor.
    Ishikawa K; Tohyama K; Mitsuhashi S; Maruta S
    J Biochem; 2014 Apr; 155(4):257-63. PubMed ID: 24451491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A structural change in the kinesin motor protein that drives motility.
    Rice S; Lin AW; Safer D; Hart CL; Naber N; Carragher BO; Cain SM; Pechatnikova E; Wilson-Kubalek EM; Whittaker M; Pate E; Cooke R; Taylor EW; Milligan RA; Vale RD
    Nature; 1999 Dec; 402(6763):778-84. PubMed ID: 10617199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical Genetics Approach to Engineer Kinesins with Sensitivity towards a Small-Molecule Inhibitor of Eg5.
    Möckel MM; Hund C; Mayer TU
    Chembiochem; 2016 Nov; 17(21):2042-2045. PubMed ID: 27550380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Docking and rolling, a model of how the mitotic motor Eg5 works.
    Rosenfeld SS; Xing J; Jefferson GM; King PH
    J Biol Chem; 2005 Oct; 280(42):35684-95. PubMed ID: 16115880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant decrease of ADP release rate underlies the potent activity of dimethylenastron to inhibit mitotic kinesin Eg5 and cancer cell proliferation.
    Sun L; Sun X; Xie S; Yu H; Zhong D
    Biochem Biophys Res Commun; 2014 May; 447(3):465-70. PubMed ID: 24732354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Allosteric Pathway of Eg5 Regulation Identified through Multivariate Statistical Analysis of Hydrogen-Exchange Mass Spectrometry (HX-MS) Ligand Screening Data.
    Sheff JG; Farshidfar F; Bathe OF; Kopciuk K; Gentile F; Tuszynski J; Barakat K; Schriemer DC
    Mol Cell Proteomics; 2017 Mar; 16(3):428-437. PubMed ID: 28062800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.